129 related articles for article (PubMed ID: 23554308)
1. A pH-sensitive binary drug delivery system based on poly(caprolactone)-heparin conjugates.
Ye L; Gao Z; Zhou Y; Yin X; Zhang X; Zhang A; Feng Z
J Biomed Mater Res A; 2014 Mar; 102(3):880-9. PubMed ID: 23554308
[TBL] [Abstract][Full Text] [Related]
2. Sustained release of PTX-incorporated nanoparticles synergized by burst release of DOX⋅HCl from thermosensitive modified PEG/PCL hydrogel to improve anti-tumor efficiency.
Xu S; Wang W; Li X; Liu J; Dong A; Deng L
Eur J Pharm Sci; 2014 Oct; 62():267-73. PubMed ID: 24931190
[TBL] [Abstract][Full Text] [Related]
3. Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells.
Zhong Y; Yang W; Sun H; Cheng R; Meng F; Deng C; Zhong Z
Biomacromolecules; 2013 Oct; 14(10):3723-30. PubMed ID: 23998942
[TBL] [Abstract][Full Text] [Related]
4. pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles.
Chen W; Meng F; Cheng R; Zhong Z
J Control Release; 2010 Feb; 142(1):40-6. PubMed ID: 19804803
[TBL] [Abstract][Full Text] [Related]
5. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
6. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
7. Oxime linkage: a robust tool for the design of pH-sensitive polymeric drug carriers.
Jin Y; Song L; Su Y; Zhu L; Pang Y; Qiu F; Tong G; Yan D; Zhu B; Zhu X
Biomacromolecules; 2011 Oct; 12(10):3460-8. PubMed ID: 21863891
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers.
Dong DW; Tong SW; Qi XR
J Biomed Mater Res A; 2013 May; 101(5):1336-44. PubMed ID: 23065848
[TBL] [Abstract][Full Text] [Related]
9. Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery.
Shahin M; Lavasanifar A
Int J Pharm; 2010 Apr; 389(1-2):213-22. PubMed ID: 20080163
[TBL] [Abstract][Full Text] [Related]
10. A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment.
Zhang Y; Tang L; Sun L; Bao J; Song C; Huang L; Liu K; Tian Y; Tian G; Li Z; Sun H; Mei L
Acta Biomater; 2010 Jun; 6(6):2045-52. PubMed ID: 19969111
[TBL] [Abstract][Full Text] [Related]
11. pH-sensitive micelles self-assembled from multi-arm star triblock co-polymers poly(ε-caprolactone)-b-poly(2-(diethylamino)ethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) for controlled anticancer drug delivery.
Yang YQ; Zhao B; Li ZD; Lin WJ; Zhang CY; Guo XD; Wang JF; Zhang LJ
Acta Biomater; 2013 Aug; 9(8):7679-90. PubMed ID: 23669619
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticle carriers based on copolymers of poly(ε-caprolactone) and hyperbranched polymers for drug delivery.
Wang T; Li M; Gao H; Wu Y
J Colloid Interface Sci; 2011 Jan; 353(1):107-15. PubMed ID: 20947092
[TBL] [Abstract][Full Text] [Related]
13. Dendronized heparin-doxorubicin conjugate based nanoparticle as pH-responsive drug delivery system for cancer therapy.
She W; Li N; Luo K; Guo C; Wang G; Geng Y; Gu Z
Biomaterials; 2013 Mar; 34(9):2252-64. PubMed ID: 23298778
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin-loaded nanosized micelles of a star-shaped poly(ε-caprolactone)-polyphosphoester block co-polymer for treatment of human breast cancer.
Cuong NV; Hsieh MF; Chen YT; Liau I
J Biomater Sci Polym Ed; 2011; 22(11):1409-26. PubMed ID: 20594418
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of carboxymethyl chitosan/poly(ε-caprolactone)/doxorubicin/nickel ferrite core-shell fibers for controlled release of doxorubicin against breast cancer.
Abasalta M; Asefnejad A; Khorasani MT; Saadatabadi AR
Carbohydr Polym; 2021 Apr; 257():117631. PubMed ID: 33541657
[TBL] [Abstract][Full Text] [Related]
16. Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release.
Chen W; Zhong P; Meng F; Cheng R; Deng C; Feijen J; Zhong Z
J Control Release; 2013 Aug; 169(3):171-9. PubMed ID: 23306022
[TBL] [Abstract][Full Text] [Related]
17. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy.
Gu Y; Zhong Y; Meng F; Cheng R; Deng C; Zhong Z
Biomacromolecules; 2013 Aug; 14(8):2772-80. PubMed ID: 23777504
[TBL] [Abstract][Full Text] [Related]
18. Cancer therapy and fluorescence imaging using the active release of doxorubicin from MSPs/Ni-LDH folate targeting nanoparticles.
Li D; Zhang YT; Yu M; Guo J; Chaudhary D; Wang CC
Biomaterials; 2013 Oct; 34(32):7913-22. PubMed ID: 23886730
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous controlled release of 5-FU, DOX and PTX from chitosan/PLA/5-FU/g-C3N4-DOX/g-C3N4-PTX triaxial nanofibers for breast cancer treatment in vitro.
Habibi Jouybari M; Hosseini S; Mahboobnia K; Boloursaz LA; Moradi M; Irani M
Colloids Surf B Biointerfaces; 2019 Jul; 179():495-504. PubMed ID: 31005745
[TBL] [Abstract][Full Text] [Related]
20. Redox-sensitive self-assembled nanoparticles based on alpha-tocopherol succinate-modified heparin for intracellular delivery of paclitaxel.
Yang X; Cai X; Yu A; Xi Y; Zhai G
J Colloid Interface Sci; 2017 Jun; 496():311-326. PubMed ID: 28237749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
